Academic Department of Trauma and Orthopaedics Surgery, School of Medicine, University of Leeds, Leeds General Infirmary, Clarendon Wing, Floor D, Great George Street, Leeds, LS1 3EX, UK.
NIHR Leeds Biomedical Research Centre, Chapel Allerton Hospital, Leeds, UK.
Eur J Trauma Emerg Surg. 2024 Jun;50(3):705-721. doi: 10.1007/s00068-023-02375-w. Epub 2023 Nov 3.
Infected tibial non-unions with associated bone loss can be challenging to manage. At present, the two main methods utilized in the management of these fractures include the Ilizarov technique of Distraction Osteogenesis (DO) using external fixator devices, or alternatively, the Induced Membrane Technique (IMT), devised by Masquelet. As there is a paucity of data directly comparing the outcomes of these techniques, there is no universal agreement on which strategy a surgeon should choose to use.
This systematic review and meta-analysis aimed to summarize the outcomes of both DO and IMT, in terms of primary outcomes (bone union and infection elimination), and secondary outcomes (complication rates and functional outcomes).
A PRISMA strategy was used. Medline, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), and Google Scholar library databases were interrogated using pre-defined MeSH terms and Boolean operators. Quality of evidence was evaluated using OCEBM and GRADE systems.
Thirty-two studies with 1136 subjects met the inclusion criteria. With respect to the primary outcomes of interest, union was observed in 94.6% (DO method) and 88.0% (IMT method); this difference, however, was not significant between the two techniques (p = 0.45). In addition, infection elimination rates were also higher in the Ilizarov DO group when compared to Masquelet (Mq) IMT (93.0% vs 80.4% respectively). Again, no significant difference was observed (p = 0.06). For all secondary outcomes assessed (unplanned re-operations, re-fracture rates amputation rate), no statistically significant differences were documented between the treatment options.
This study demonstrated that there is no clinical difference in outcomes for patients treated with Ilizarov DO versus Mq IMT techniques. The evidence base at present is relatively sparse and, therefore, we would recommend for further Level I studies to be conducted, to make more meaningful conclusions.
感染性胫骨骨不连伴骨缺损的治疗极具挑战性。目前,治疗这些骨折的两种主要方法包括伊利扎罗夫(Ilizarov)牵张成骨技术(DO)和 Masquelet 诱导膜技术(IMT)。由于缺乏直接比较这两种技术治疗效果的资料,因此,对于外科医生应该选择哪种策略,目前尚无共识。
本系统评价和荟萃分析旨在总结 DO 和 IMT 的治疗效果,包括主要结果(骨愈合和感染消除)和次要结果(并发症发生率和功能结果)。
采用 PRISMA 策略。使用预定义的 MeSH 术语和布尔运算符,对 Medline、Web of Science、Cochrane 中央对照试验注册库(CENTRAL)和 Google Scholar 文库数据库进行检索。使用 OCEBM 和 GRADE 系统评估证据质量。
符合纳入标准的 32 项研究共纳入 1136 例患者。在主要研究结果方面,DO 组的愈合率为 94.6%,IMT 组为 88.0%,但两组间差异无统计学意义(p=0.45)。此外,与 Masquelet IMT 组相比,Ilizarov DO 组的感染消除率更高(93.0% vs. 80.4%),但差异无统计学意义(p=0.06)。对于所有评估的次要结果(计划外再次手术、再骨折率、截肢率),两种治疗方法之间也未观察到统计学差异。
本研究表明,采用 Ilizarov DO 与 Masquelet IMT 技术治疗患者的结果无临床差异。目前的证据基础相对较少,因此,我们建议进行更多的一级研究,以得出更有意义的结论。